COMMUNIQUÉS West-GlobeNewswire

iTeos Therapeutics SA: Appoints Mohamed Ragab, M.D. as Vice President, Corporate Development
29/06/2017
iTeos Therapeutics Appoints Mohamed Ragab, M.D. as Vice President, Corporate Development Joins from Bristol Myers Squibb to accelerate global partnering Gosselies, Belgium - June 29, 2017 - iTeos Therapeutics SA, a [...]
ObsEva Announces Presentations Related to its Assisted Reproductive Technology (ART) and Pre-term labor (PTL) Development Programs at ESHRE 2017 Annual Meeting
29/06/2017
Phase 2 nolasiban previously reported data supports potential for meaningfully increasing live birth rates in ART Non-clinical results of OBE022 for PTL demonstrate both monotherapy/combination potential Geneva, [...]
TiGenix opens US headquarters in Cambridge, MA
29/06/2017
PRESS RELEASE TiGenix opens US headquarters in Cambridge, MA Decision follows NASDAQ IPO in 2016 and the launch of the global phase III trial for Cx601 Operations to be based in Cambridge at heart of Boston area biotech [...]
TiGenix ouvre à Cambridge (Massachusetts) son siège central aux États-Unis
29/06/2017
COMMUNIQUÉ DE PRESSE TiGenix ouvre à Cambridge (Massachusetts) son siège central aux États-Unis La décision suit l'OPV de NASDAQ en 2016 et le lancement de l'essai clinique global de phase III pour Cx601 Les opérations [...]
Bio-on presents "The Matter". Bioplastic technology now open source for researchers around the world
29/06/2017
Bio-on presents "The Matter". Bioplastic technology now open source for researchers around the world Bio-on will make its natural and 100% biodegradable bioplastic, Minerv PHAs, available free of charge to researchers, [...]
Bio-on présente «The Matter». La technologie du bioplastique est désormais « Open source » au service des chercheurs du monde entier.
29/06/2017
Bio-on présente « The Matter ». La technologie du bioplastique est désormais « Open source » au service des chercheurs du monde entier. Bio-on mettra gratuitement le bioplastique naturel et entièrement (100%) [...]
Novartis receives EU approval for first-line use of Zykadia® in ALK-positive advanced non-small cell lung cancer (NSCLC)
29/06/2017
In ALK-positive advanced NSCLC patients, Zykadia demonstrated superior median progression-free survival (PFS) compared to SOC chemotherapy with maintenance[1] Zykadia benefit was also seen in patients with brain [...]
Minerva Neurosciences Announces Pricing of Public Offering of Common Stock
29/06/2017
WALTHAM, Mass., June 28, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 5,000,000 shares [...]
Vectura Group plc: New development and licence agreement for a US inhaled generic (VR2081)
28/06/2017
Vectura Group plc New development and licence agreement for a US inhaled generic (VR2081) Chippenham, UK - 28 June 2017: Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading device and formulation [...]
Innocoll Announces Scheme Meeting and Extraordinary General Meeting Voting Results
28/06/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION FOR IMMEDIATE [...]
AC IMMUNE ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING
28/06/2017
Lausanne, Switzerland, June 28, 2017 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative diseases, today announced that the shareholders of the Company [...]
Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics
28/06/2017
Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics Funding to advance gene therapies targeting orphan paediatric disorders through clinical trials LONDON, 28 June, 2017: Arix [...]
Medtronic SureTune(TM)3 Earns CE Mark for Deep Brain Stimulation Therapy
28/06/2017
Data Presented at the 17th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery in Berlin DUBLIN and BERLIN - June 28, 2017 - Medtronic plc (NYSE: MDT) today announced it has received CE [...]
Summit Therapeutics plc : Grant of Share Options
28/06/2017
Summit Therapeutics plc ("Summit" or the "Company") GRANT OF SHARE OPTIONS Oxford, UK, 28 June 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for [...]
Summit Therapeutics plc : Exercise of Share Options
28/06/2017
Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 28 June 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies [...]
MITHRA SIGNS EXCLUSIVE LICENSE AND SUPPLY AGREEMENT WITH FUJI PHARMA FOR DONESTA® IN JAPAN AND ASEAN
28/06/2017
Mithra signs EXclusive license and supply agreement with FUJI Pharma for donesta® in japan and asean Fuji Pharma obtains rights to commercialize Donesta®, Mithra's Hormone Therapy (HT) product candidate based on [...]
MDxHealth Presents Three SelectMDx Studies at 5th Global Congress on Prostate Cancer
28/06/2017
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, June 28 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced its activities at the fifth Global Congress on [...]
MDxHealth présente trois études SelectMDx lors du 5e congrès mondial sur le cancer de la prostate
28/06/2017
COMMUNIQUE DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, et HERSTAL, BELGIQUE - 07:00 AM CEST - Le 28 juin 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui ses activités lors [...]
Minerva Neurosciences, Inc. to Offer Common Shares
27/06/2017
WALTHAM, Mass., June 27, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 5,000,000 shares of its common [...]

Pages